Artificial Intelligence
Nijmegen, Netherlands – Aiosyn, a pioneering medical software company specializing in AI-powered pathology solutions for cancer and kidney disease, announced the introduction of its NephroPath platform. By partnering with Aiosyn,...
The College of American Pathologists (CAP) has updated its evidence-based guideline for analytic validation of immunohistochemical (IHC) assays to provide increased accuracy and consistency in laboratory practices. Many of the...
Proscia: Paving the way to advance cancer research and diagnosis with enriched, high-quality DICOM images CAMBRIDGE, Mass. and PHILADELPHIA – February 27, 2024 – Proscia®, a leading provider of digital and computational pathology...
From the Medriva Blog Revolutionizing Digital Pathology with Deep Learning In the rapidly evolving landscape of healthcare and medicine, artificial intelligence (AI) and deep learning (DL) techniques are emerging as transformative tools,...
Lunit: A new study published in the Journal for ImmunoTherapy of Cancer (JITC) shows that Lunit's AI-powered biomarker "Lunit SCOPE IO" can predict favorable outcomes of Inflamed Immune Phenotype patients treated with Immune Checkpoint...
Proscia Ready advances increasingly comprehensive approach for realizing the full promise of digitization PHILADELPHIA – February 20, 2024 –Proscia®, a leading provider of digital and computational pathology solutions, has established a...
